Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Transcenta Holding Receives FDA Clearance to Proceed with Global Phase III Trial of Osemitamab

Wednesday, October 04, 2023

Transcenta Holding has received FDA clearance to proceed with the TranStar global Phase III pivotal trial of Osemitamab TST in combination with Nivolumab and chemotherapy as a firstline treatment for patients with HERnegative CLDN expressing locally...

Pfizer Announces Availability of Rimegepant in Hong Kong for Migraine Management

Tuesday, October 03, 2023

Pfizer has made an announcement regarding the availability of Rimegepant in Hong Kong marking a significant milestone as it becomes the first Asian market to offer this calcitonin generelated peptide CGRP receptor antagonist for the management of mig...

WuXi Biologics Congratulates Amicus Therapeutics on FDA Approval for Pompe Disease Treatment

Tuesday, October 03, 2023

This innovative twocomponent therapy is specifically intended for adults with lateonset Pompe disease LOPD weighing kg who are not experiencing improvements with their current enzyme replacement therapy ERT

Structural Genomics Consortium and HitGen Announce Research Collaboration

Friday, September 29, 2023

HitGen has announced a strategic partnership with the Structural Genomics Consortium SGC with the aim of accelerating the discovery of new medicines through openaccess research In this collaboration HitGen will leverage its cuttingedge DNAencoded lib...

Ono Pharmaceutical Enters into Drug Discovery Collaboration Agreement with Adimab

Thursday, September 28, 2023

Ono Pharmaceutical announced collaboration agreement with Adimab to discover and develop innovative antibody drugs in the oncology field

BioCity Biopharm and AstraZeneca Enter into Collaboration Agreement

Thursday, September 28, 2023

BioCity Biopharma and AstraZeneca have entered into a collaborative agreement aimed at conducting a Phase IbII clinical study

Gracell Biotechnologies Initiates Phase 1b/2 Trial for GC012F in Relapsed/Refractory Multiple Myeloma

Wednesday, September 27, 2023

Gracell announced that it has initiated a phase b clinical trial in the United States with the dosing of the first patient to assess its lead candidate GCF in individuals with relapsed or refractory multiple myeloma RRMM

RemeGen Obtains Positive Phase III Results for New Drug Telitacicept(RC18)

Wednesday, September 27, 2023

RemeGen announced the positive results in a phase III clinical study of Telitacicept RC for the treatment of rheumatoid arthritis RA in China

GSK Receives Approval for Arexvy as the First RSV Vaccine for Older Adults

Tuesday, September 26, 2023

GSK has received approval from Japans Ministry of Health Labour and Welfare MHLW for Arexvy a recombinant adjuvanted vaccine designed to protect adults aged years and older from respiratory syncytial virus RSV disease

Chime Biologics Enters into Agreement with Kings Pharm

Tuesday, September 26, 2023

Chime Biologics has entered into a strategic partnership with Kings Pharm This collaboration signifies a significant development in the field of biologics particularly in the context of biosimilar projects